| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |